🧬Notice of Grant Opportunities from the National Human Genome Research Institute
The Department of Health and Human Services announces closed meetings of the National Human Genome Research Institute’s panels to review grant applications. Meetings will focus on evaluating the proposals, including potential commercial implications and ethical considerations, aimed at advancing genome research. The sessions will be held virtually, ensuring accessibility for all involved stakeholders.
Learn More🔬Notice of Closed NIH Meeting on Grant Applications Review
The Department of Health and Human Services announces a closed meeting for the National Institute of Allergy and Infectious Diseases Special Emphasis Panel. The meeting will evaluate grant applications related to allergy, immunology, and infectious diseases, focusing on the confidentiality of trade secrets and personal information concerning applicants.
Learn More🏥Notice of Closed Meeting for Eunice Kennedy Shriver National Institute
The Department of Health and Human Services announces a closed meeting for the Eunice Kennedy Shriver National Institute of Child Health and Human Development to evaluate contract proposals. The virtual meeting aims to review significant contract discussions related to pediatric research and development, ensuring confidentiality in proposals and discussions.
Learn More💰NIH Grant Application Review Meetings - Business Opportunities
The Department of Health and Human Services announces closed meetings for the NIH's Center for Scientific Review to evaluate and review grant applications. These virtual meetings focus on various scientific and research areas, highlighting potential funding opportunities for businesses engaged in health and scientific research.
Learn More🏥NIH Notice of Closed Meeting on Rapid Diagnostic Proposals
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review contract proposals for developing rapid diagnostic assays for self-monitoring HIV-1 infections. The meeting will evaluate confidential materials, highlighting the importance of compliance with trade secret protections. Affected stakeholders include those in the healthcare technology field.
Learn More💰NIH Grant Application Review Meeting Announcement
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to review grant applications for developing tools to combat antibiotic-resistant bacteria. The meeting, scheduled for April 2025, aims to evaluate and discuss confidential materials related to health research funding.
Learn More🏥National Cancer Institute Notice on Grant Review Meetings
The National Cancer Institute announces closed meetings to review grant applications related to diet, lipid metabolism, and cancer. These meetings are in compliance with federal law and focus on evaluating grant applications, likely affecting confidential trade secrets and personal privacy issues within the field.
Learn More🧬NIH Notice of Closed Meeting on Grant Applications
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to evaluate grant applications related to immunobiology and xenotransplantation. The meeting, scheduled for April 2025, will discuss confidential information to ensure the protection of trade secrets and personal data associated with the applications.
Learn More🏥Notice of Closed Meeting for Grant Application Review by NIH
The National Institutes of Health announces a closed meeting of the Heart, Lung, and Blood Initial Review Group to evaluate grant applications. The event will be conducted virtually, ensuring confidentiality around sensitive information. The meeting indicates ongoing engagement in health-related research opportunities and discussions among key stakeholders.
Learn More💊NIH Announces Closed Meetings for Grant Evaluations in Drug Research
The Department of Health and Human Services announces closed meetings held by the National Institute on Drug Abuse to review grant applications and contract proposals addressing issues related to drug abuse. These meetings are crucial for organizations seeking funding and insights into research on drug-related topics, particularly those impacting structural racism and treatment methods.
Learn More